Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 31, 2022
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
Tue, August 30, 2022
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
[ Tue, Aug 30th 2022
] - WOPRAI
James Molloy Initiated (AQST) at Strong Buy and Held Target at $10 on, Aug 30th, 2022
James Molloy of Alliance Global Partners, Initiated "Aquestive Therapeutics, Inc." (AQST) at Strong Buy and Held Target at $10 on, Aug 30th, 2022.
James has made no other calls on AQST in the last 4 months.
There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with James's Rating of Hold.
This is the rating of the analyst that currently disagrees with James
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Monday, August 15th, 2022
